Angelos E. Halaris
#143,911
Most Influential Person Now
Angelos E. Halaris's AcademicInfluence.com Rankings
Angelos E. Halarismedical Degrees
Medical
#2670
World Rank
#3101
Historical Rank
Pharmacology
#290
World Rank
#339
Historical Rank
Angelos E. Halarisphilosophy Degrees
Philosophy
#7652
World Rank
#10893
Historical Rank
Ontology
#82
World Rank
#92
Historical Rank
Logic
#4697
World Rank
#6018
Historical Rank
Download Badge
Medical Philosophy
Why Is Angelos E. Halaris Influential?
(Suggest an Edit or Addition)Angelos E. Halaris's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Serotonin neurons of the midbrain raphe: Ascending projections (1978) (810)
- Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder (2001) (569)
- Hippocampal innervation by serotonin neurons of the midbrain raphe in the rat (1975) (313)
- Effects of locus coeruleus lesions upon cerebral monoamine content, sleep-wakefulness states and the response to amphetamine in the cat (1977) (275)
- Ascending projections of the locus coeruleus in the rat. I. axonal transport in central noradrenaline neurons (1977) (246)
- Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. (1995) (225)
- Agmatine : metabolic pathway and spectrum of activity in brain. (2007) (220)
- Agmatine: clinical applications after 100 years in translation. (2013) (191)
- Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. (2019) (187)
- Aphagia and adipsia after preferential destruction of nerve cell bodies in hypothalamus. (1978) (183)
- Reduced Neuropeptide Y Concentrations in Suicide Brain (1992) (151)
- Circadian rhythm of tryptophan, serotonin, melatonin, and pituitary hormones in schizophrenia (1994) (149)
- Circadian rhythms in psychiatry The Boxwood Press, Pacific Grove, CA (1983). 270 pp (1984) (144)
- Agonist Binding to α2‐Adrenoceptors Is Elevated in the Locus Coeruleus from Victims of Suicide (1994) (143)
- Pro-inflammatory biomakers in depression: Treatment with venlafaxine (2009) (137)
- Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease. (2017) (130)
- Antidepressant drugs affect dopamine uptake. (1975) (127)
- A 1 year double‐blind placebo‐controlled fixed dose study of sertraline in the treatment of obsessive‐compulsive disorder (1995) (123)
- Origin and distribution of 3-methoxy-4-hydroxyphenylglycol in body fluids. (1979) (102)
- Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection. (1997) (99)
- Inflammation, Heart Disease, and Depression (2013) (98)
- Comorbidity between depression and cardiovascular disease. (2009) (93)
- Axonal transport in serotonin neurons of the midbrain raphe (1976) (92)
- VEGF and depression: a comprehensive assessment of clinical data. (2013) (90)
- STOICHIOMETRIC RELATION OF PROTEIN COMPONENTS IN CEREBRAL MYELIN FROM DIFFERENT SPECIES 1 (1970) (84)
- Chronobiology and psychiatric disorders (1989) (78)
- Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia (1995) (73)
- Normal thyroid function in desipramine nonresponders converted to responders by the addition of L-triiodothyronine. (1984) (70)
- Effect of Agmatine Against Cell Death Induced by NMDA and Glutamate in Neurons and PC12 Cells (2003) (69)
- Does escitalopram reduce neurotoxicity in major depression? (2015) (68)
- Characterization of subtypes of alpha-2 adrenoceptors in the human brain. (1993) (68)
- Psychopharmacology of imidazoline and alpha 2-adrenergic receptors: implications for depression. (1994) (67)
- Plasma Agmatine and Platelet Imidazoline Receptors in Depression a (1999) (64)
- Evaluation of studies on platelet alpha 2 adrenoreceptors in depressive illness. (1986) (62)
- A 2‐year study of sertraline in the treatment of obsessive‐compulsive disorder (1997) (62)
- Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. (1994) (61)
- Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients. (1991) (56)
- Binding of [3H]-p-aminoclonidine to alpha 2-adrenoceptor states plus a non-adrenergic site on human platelet plasma membranes. (1991) (55)
- Relevance of Imidazoline Receptors and Agmatine to Psychiatry: A Decade of Progress (2003) (50)
- The relationship between life stress and depression in an endogenous sample. (1990) (46)
- Elevated 3H-para-aminoclonidine binding to platelet purified plasma membranes from depressed patients. (1990) (46)
- Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder. (1996) (45)
- Elevated P-selectin on platelets in depression: response to bupropion. (2000) (44)
- Predicting response to fluoxetine in geriatric patients with major depression. (1995) (43)
- CSF and endocrine studies of premenstrual syndrome. (1991) (43)
- Increased imidazoline and α 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes (1993) (40)
- Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. (2018) (37)
- Platelet I1-imidazoline binding sites are decreased by two dissimilar antidepressant agents in depressed patients. (1996) (36)
- Sucrose and quinine intake by maternally-deprived and control rhesus monkeys (2000) (36)
- Effects of central norepinephrine depletion on the initiation and maintenance of maternal behavior in the rat (1977) (35)
- Deficits in food and water intake after knife cuts that deplete striatal DA or hypothalamic NE in rats (1977) (35)
- Neurochemical Aspects of the Sexual Response Cycle (2003) (35)
- Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression (2000) (35)
- Vascular Endothelial Growth Factor: a potential diagnostic biomarker for major depression. (2014) (34)
- Inflammation and depression but where does the inflammation come from? (2019) (33)
- A correlational analysis of the effects of surgical transections of three components of the MFB on ingestive behavior and hypothalamic, striatal, and telencephalic amine concentrations (1977) (32)
- Modulation of the inflammatory response benefits treatment-resistant bipolar depression: A randomized clinical trial. (2020) (32)
- Apparent phase advance in diurnal MHPG rhythm in depression. (1989) (30)
- Determination of plasma 3-methoxy-4-hydroxyphenyl-glycol by pulsed electron capture gas chromatography. (1977) (30)
- Psychoendocrine sequelae of chronic testosterone deficiency. (1999) (28)
- Super high affinity 3H-Para-Aminoclonidine binding to platelet adrenoceptors in depression (1988) (28)
- Variations in the uptake of 3H-dopamine during the estrous cycle. (1977) (27)
- Vascular endothelial growth factor: Potential predictor of treatment response in major depression (2017) (26)
- Regulatory deficits after surgical transections of three components of the MFB: Correlation with regional amine depletions (1977) (26)
- Chronic desipramine treatment reduces regional neuropeptide Y binding to Y2-type receptors in rat brain (1991) (25)
- Effects of desipramine on diurnal rhythms of plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) in depressed patients. (1982) (25)
- Bupropion in depression: a tri-center placebo-controlled study. (1983) (25)
- Comparative cardiac effects of maprotiline and doxepin in elderly depressed patients. (1984) (25)
- Effects on hypothalamic and telencephalic NE and 5-HT of tegmental knife cuts that produce hyperphagia or hyperdipsia in the rat (1977) (25)
- Treatment-Resistant Depression Revisited: A Glimmer of Hope (2021) (24)
- Hypothalamic norepinephrine: concentration and metabolism during pregnancy and lactation in the rat. (1975) (24)
- Effect of chlorimipramine on the metabolism of 5-hydroxytryptamine in the rat brain. (1973) (24)
- Co-morbidity between cardiovascular pathology and depression: role of inflammation. (2013) (23)
- Relationship between plasma antidepressant levels and clinical outcome for inpatients receiving imipramine. (1982) (22)
- Persistent disturbance of the hypothalamic-pituitary-gonadal axis in abstinent alcoholic men. (2003) (22)
- Low cardiac vagal tone index by heart rate variability differentiates bipolar from major depression (2019) (21)
- Hyperdopaminergia in schizophreniform psychosis: A chronobiological study (1993) (21)
- Behavioral and biochemical effects of knife cuts that preferentially interrupt principal afferent and efferent connections of the striatum in the rat (1977) (20)
- Vesicular and juxtavesicular serotonin: effects of lysergic acid diethylamide and reserpine. (1977) (20)
- Effect of bupropion on immunodensity of putative imidazoline receptors on platelets of depressed patients. (1999) (20)
- Diurnal rhythm of 3-methoxy-4-hydroxyphenylglycol (MHPG): relationship between plasma and urinary levels. (1985) (20)
- ACTIVE UPTAKE OF [3H]5‐HT BY SYNAPTIC VESICLES FROM RAT BRAIN (1978) (19)
- Platelet imidazoline receptors as state marker of depressive symptomatology. (2008) (19)
- Therapeutic superiority of maprotiline versus doxepin in geriatric depression (1983) (19)
- Plasma MHPG response to yohimbine treatment in women with hypoactive sexual desire. (1998) (19)
- Loss of body weight as a predictor of reserpine-induced amine depletion. (1975) (18)
- Some biochemical effects of zona incerta lesions that interfere with the regulation of water intake (1977) (17)
- Indoleamine compartmentation in human blood. (1978) (17)
- Shared Neurobiological Pathways Between Type 2 Diabetes and Depressive Symptoms: a Review of Morphological and Neurocognitive Findings (2014) (16)
- Innervation of forebrain regions by medullary noradrenaline neurons, a biochemical study in cats with central tegmental tract lesions (1978) (16)
- Open label evaluation of the novel antipsychotic compound BW234U in chronic schizophrenics (1985) (16)
- Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression (2001) (16)
- Psychocardiology: moving toward a new subspecialty. (2013) (15)
- Depression and atherosclerosis. (2011) (15)
- Autoradiographic Comparison of [3H]-Clonidine Binding to Non-Adrenergic Sites and α2-Adrenergic Receptors in Human Brain (2000) (15)
- Changes in the metabolism of hypothalamic norepinephrine associated with the onset of maternal behavior in the nulliparous rat (1976) (14)
- Dimensions of depression: A comparative longitudinal study (1989) (14)
- Ultrastructural changes in the gastric mucosa after truncal vagotomy. (1971) (14)
- Chronic imipramine treatment downregulates IR1-imidazoline receptors in rat brainstem. (1997) (14)
- Antidepressant Drug Therapy in the Elderly: Enhancing Safety and Compliance (1987) (14)
- Rat brain aryl acylamidase: stereospecific inhibition by LSD and serotonin‐related compounds (1976) (13)
- STUDIES OF NOREPINEPHRINE METABOLISM IN MANIC AND DEPRESSIVE STATES (1979) (13)
- Effects of neuropeptide Y on alpha1- and beta-adrenoceptor-stimulated second messenger systems in rat frontal cortex (1990) (13)
- Interactions between neuropeptide Y and alpha2-adrenoceptors in selective rat brain regions (1991) (13)
- Clinical efficacy of the new antidepressant bupropion (Wellbutrin) [proceedings]. (1981) (13)
- Evaluation of the safety and efficacy of bupropion in depression. (1983) (13)
- A Primary Care Focus on the Diagnosis and Treatment of Major Depressive Disorder in Adults (2011) (13)
- Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment. (2002) (13)
- Effects of adjunctive inflammatory modulation on IL-1β in treatment resistant bipolar depression (2020) (12)
- Involvement of I1‐Imidazoline Receptors in Mood Disorders (1995) (11)
- Differential expression of alpha2-adrenoceptor vs. imidazoline binding sites in postmortem orbitofrontal cortex and amygdala of depressed subjects. (2003) (11)
- Serum BDNF: A Potential Biomarker for Major Depressive Disorder and Antidepressant Response Prediction (2015) (11)
- A Comparison of the Binding of [3H]Proprionyl‐Neuropeptide Y to Rat and Human Frontal Cortical Membranes (1990) (11)
- Inflammation control reverses treatment-resistance in bipolar depression (2014) (11)
- Vascular endothelial growth factor in bipolar depression: A potential biomarker for diagnosis and treatment outcome prediction (2020) (11)
- Electroencephalographic changes and other indices of neurotoxicity with haloperidol-lithium therapy. (1989) (11)
- Celecoxib augmentation of escitalopram in treatment-resistant bipolar depression and the effects on Quinolinic Acid (2019) (10)
- Relationship between membrane fluidity and adrenoceptor binding in depression (1991) (10)
- INFLUENCE OF GONADAL HORMONES ON NEUROTRANSMITTERS, RECEPTOR, COGNITION AND MOOD (1992) (10)
- Diminution of Heart Rate Variability in Bipolar Depression (2017) (10)
- Disruption of circadian MHPG rhythmicity in major depression (1994) (10)
- Compartmentation of catecholamines in rat brain: Effects of agonists and antagonists (1980) (9)
- Inflammation in Psychiatry (2013) (9)
- Plasma MCP-1 levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. (2020) (9)
- Ion transport and adrenergic function in major affective disorder. (1982) (9)
- Effect of a benzoquinolizine (RO 4-1284) on granulated vesicles of the rat brain (2004) (9)
- State dependence of noradrenergic activity in a rapidly cycling bipolar patient. (1984) (9)
- Neuroprogression in Psychiatric Disorders (2017) (8)
- Multimodality Imaging in a Depressed Patient with Violent Behavior and Temporal Lobe Seizures (2007) (8)
- Yohimbine and clonidine recognize different states of adrenergic receptors on human platelets: reconsideration of studies on platelet alpha-2 receptors in depressive illness. (1985) (8)
- Plasma corticoids and brain tryptophan after acute and tolerance dosage of LSD. (1975) (8)
- Central cholinergic effects of tricyclic antidepressants in mouse. (1982) (8)
- Pharmacological and Nonpharmacological Interventions to Arrest Neuroprogression in Psychiatric Disorders. (2017) (8)
- A Review of the Global Impact of the COVID-19 Pandemic on Public Mental Health, with a Comparison Between the USA, Australia, and Poland with Taiwan and Thailand (2021) (8)
- Panic attack precipitated by fluoxetine. (1989) (7)
- Nitric oxide branch of arginine metabolism in depression: effect of venlafaxine. (2009) (7)
- Metabolic Syndrome Reversal With Cariprazine. (2019) (7)
- α2-Adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age (1998) (7)
- Open trial evaluation of a pyrrolidine derivative (AHR-1118) on norepinephrine metabolism. (1980) (7)
- Post-ECT asterixis associated with primary hyperparathyroidism. (1978) (7)
- Heart Rate Variability Predicts Treatment Outcome in Major Depression (2017) (7)
- Rat brain aryl acylamidase: multiple forms and inhibition effects of LSD, serotonin and related compounds. (1977) (6)
- Action of the antidepressant pridefine (AHR-1118) on biogenic amines in the rat brain. (1980) (6)
- Noncompetitive Amine Uptake Inhibition by the New Antidepressant Pridefine (1981) (6)
- Effects of tricyclic antidepressants on muscarinic cholinergic receptor binding in mouse brain. (1981) (6)
- Noncardiac chest pain: systematic review of the literature on prognosis (2018) (5)
- NORADRENALINE METABOLISM IN A MANIC-DEPRESSIVE PATIENT (1978) (5)
- Variations in the uptake of 3H-norepinephrine during the rat estrous cycle. (1977) (5)
- Unraveling the complex interplay of immunometabolic systems that contribute to the neuroprogression of psychiatric disorders (2019) (5)
- Neurological disorders, depression and inflammation: is there a common link? (2015) (5)
- Norepinephrine and 5-hydroxytryptamine in the CNS of rats under continuous illumination and total darkness. (1967) (4)
- Alpha 2-adrenoceptors and I1-imidazoline binding sites: relationship with catecholamines in women of reproductive age. (1998) (4)
- The Future of Psychoneuroimmunology: Promises and Challenges (2018) (4)
- MHPG circadian rhythmicity in blood of healthy subjects. (1990) (4)
- Biological studies in adult attention deficit disorder: case report. (1982) (4)
- Effects of inflammation modulation on tryptophan and kynurenine pathway regulation in treatment resistant bipolar depression (2019) (4)
- Gas-liquid chromatographic method for routine detection of plasma sulfo-, gluco-, and free 3-methoxy-4-hydroxyphenylglycol. (1989) (4)
- Psychotropic drugs and dopamine uptake inhibition. (1975) (4)
- Rat brain de-acetylating activity: stereospecific inhibition by LSD and serotonin-related compounds. (1976) (4)
- Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study. (1985) (4)
- P-6-14 Long-term sertraline treatment of obsessive compulsive disorder: A 2 year study (1995) (4)
- Identifying and managing borderline personality patients. (1984) (4)
- Combination therapy or monotherapy for the depressed type of schizoaffective disorder (2009) (4)
- Expression of PON1, PON2, PON3 and MPO Genes in Patients with Depressive Disorders (2022) (4)
- The raphe neuronal system and serotonergic effects of LSD (1982) (4)
- Intensity-Dependent Auditory Evoked Potential Defines Subgroups of Patients with PTSD: A Multimodality Imaging Study (2009) (3)
- 774. Modulation of Immune System Activation May Arrest Neuroprogression in Bipolar Disorder (2017) (3)
- Serotonin Syndrome Following Septal Myectomy in Association With Fentanyl and Methylene Blue: A Case Report. (2018) (3)
- Rat brain aryl acylamidase: further characterization of multiple forms. (1982) (3)
- Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine (1982) (3)
- Neuroinflammation and neurotoxicity contribute to neuroprogression in neurological and psychiatric disorders (2018) (3)
- Vitamin D Supplementation for the Treatment of Depressive Symptoms in Women with Type 2 Diabetes: A Randomized Clinical Trial (2022) (3)
- Supersensitivity to norepinephrine or dopamine antagonists after knife cuts that produce aphagia and adipsia in rats (1977) (3)
- Do Antidepressants Exert Effects on the Immune System (2015) (3)
- Plasma 3-methoxy-4-hydroxyphenylglycol in manic psychosis. (1978) (3)
- Long-term sertraline treatment of obsessive compulsive disorder: a 52-week double-blind comparative study versus placebo (1992) (3)
- 2. Tumor Necrosis Factor alpha as a biomarker in major depressive disorder (2012) (3)
- Sertraline reverses neuropeptide changes in discrete brain regions of chronic, mild stress rats (1999) (3)
- 1. Interleukin-6 as a biomarker in major depressive disorder (2012) (3)
- C-reactive protein as a potential biomarker in psychiatric practice: Are we there yet? (2021) (3)
- Imbalances in Kynurenines as Potential Biomarkers in the Diagnosis and Treatment of Psychiatric Disorders (2022) (2)
- Characterization and Isolation of Dopamine-Binding Proteins in Rat CNS by Gel Electrophoresis & Affinity Chromatography (1983) (2)
- 406. Prefrontal cell pathology distinguishes bipolar disorder from schizophrenia (2000) (2)
- Erratum to “Determination of agmatine in brain and plasma using high-performance liquid chromatography with fluorescence detection” [J. Chromatogr. B, 691 (1997) 277] (1997) (2)
- Menstrually-related changes in monoaminergic systems and their association with gonadal hormones and symptoms (1989) (2)
- Mucosal vasculature after truncal vagotomy (2005) (2)
- Effect of continuous illumination on mitochondria of the rat pineal body (1969) (2)
- Carotid Intima-Media Thickness and Circulation Markers of Inflammation in Patients With Depression (2020) (2)
- 90. Inflammation control augments antidepressant response in bipolar depression (2013) (2)
- Enhanced 3H-Para-aminoclonidine binding to two high affinity sites on platelets from depressed patients (1989) (2)
- Corrigendum to “Celecoxib augmentation of escitalopram in treatment-resistant bipolar depression and the effects on Quinolinic Acid” [Neurology, Psychiatry and Brain Research 32 (2019) June 22–29] (2020) (2)
- The Use of Lithium in Psychiatric Practice (1983) (2)
- Panels of inflammation biomarkers, growth factors and kynurenine metabolites aid in stratification of depressed patients (2016) (1)
- Effects of the potential antidepressant AHR-1118 on amine uptake and on plasma 3-methoxy-4-hydroxyphenylglycol in manic-depressive illness [proceedings]. (1979) (1)
- P-selectin in major depression: preliminary findings with venlafaxine treatment. (2010) (1)
- Electron histochemical demonstration of gangliosides in normal and Tay-Sachs brain tissue (2004) (1)
- AgmatinePathway and Spectrum of Activity in Brain (2007) (1)
- Psychocardiology: Understanding the Heart-Brain Connection: Part 1 (2018) (1)
- Circadian and Ultradian Rhythms of 3-Methoxy-4-Hydroxyphenylglycol in Subtypes of Depressive Illness (1989) (1)
- Effects of Quetiapine on Platelets in Major Depression (2016) (1)
- Does Arginine Vasopressin Reflect HPA-axis Activation in Major Depressive Disorder? (2020) (1)
- Psychocardiology, Part 2: Fixing the Broken Heart (2018) (1)
- Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression (2022) (1)
- S-27-1 Platelet immunoreactivity and radiolig and binding to imidazoline receptors in depression (1996) (1)
- 89. Isolation-reared macaques are hyposensitive to stimuli in a two-bottle choice paradigm (1996) (1)
- Autonomic Measures in Differentiating Depressive Disorders: A Potential AID (2022) (1)
- Psychiatric Comorbidity and Pharmacotherapy in Sleep Disorders (2003) (1)
- Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression? (2022) (1)
- [Ultrastructure of the gastric mucosa after specific stimulation]. (1969) (1)
- 3H-clonidine and 3H-yohimbine binding to glass fiber filters: Implications for studies with platelet membranes (2004) (1)
- S100. Elevated Matrix Metaloproteinase 9 in Treatment Resistant Bipolar Depression (2019) (0)
- Books Received (2013) (0)
- S99. Herpes Simplex Virus -1 Seropositivity in Treatment Resistant Bipolar Depression (2019) (0)
- Morphometric changes in prefrontal cortex of schizophrenic postmortem brain (1995) (0)
- S95. Plasma MCP-1 Levels in Bipolar Depression During Cyclooxygenase-2 Inhibitor Combination Treatment (2019) (0)
- 200. Vascular endothelial growth factor: A biomarker of depression may predict antidepressant response (2011) (0)
- The Glutamatergic System in Treatment-Resistant Depression and Comparative Effectiveness of Ketamine and Esketamine: Role of Inflammation? (2023) (0)
- Single nucleotide polymorphisms contribute to treatment resistant depression: effect of anti-inflammatory treatment (2023) (0)
- Mechanisms of neuroprogression and interventions to predict and arrest it (2018) (0)
- THE INFLUENCE OF ESTROGEN AND PROGESTERON ON IMIDA70LINE AND 2 BINDING SITES ‐ POSSIBLE IMPLICATIONS FOR AFFECTIVE DISORDERS (1992) (0)
- Introduction: Sexual Dysfunction: A Neglected Area of Knowledge (2003) (0)
- Imidazoline receptors: Potential markers for depression and targets of antidepressant drag development (1999) (0)
- C-Reactive Protein in Major Depressive Disorder: Promise and Challenge (2022) (0)
- Proinflammatory Status in Major Depression: Effects of Escitalopram (2010) (0)
- Sexual Dysfunction and Function (2013) (0)
- Front & Back Matter (2019) (0)
- Positive methylphenidate response and blunted thyrotropin-releasing hormone response in depression. (1986) (0)
- S94. Tumor Necrosis Factor Alpha in Major Depressive Disorder: Effects of Anti-Depressant Treatments (2019) (0)
- Inflammation is associated with cardiovascular disease and psychiatric disorders (2014) (0)
- Endothelial Dysfunction and Arterial Stiffness in Patients with Bipolar Depression (2020) (0)
- The Complex Role of Oxytocin in Major Depressive Disorder (2022) (0)
- 111. Stress, autonomic nervous system imbalance and psychopathology (2011) (0)
- 580. Effects of Anti-Depressant Treatment on Interleukin-8 in Major Depressive Disorder (2023) (0)
- Heart Rate Variability in Depression: Effect of Escitalopram (2010) (0)
- Effects of neuropeptide Y on alpha 1-and beta-adrenoceptor-stimulated second messenger systems in rat frontal cortex. (1990) (0)
- Effects of tricyclic antidepressants on acetylcholine turnover and choline uptake [proceedings]. (1979) (0)
- 201. Inflammation and endothelial dysfunction in depression and anxiety disorders (2011) (0)
- Oxide and Arginine Metabolism in Depression: Effect of a Serotonin-Norepinephrine Reuptake Inhibitor (2009) (0)
- REM sleep suppression in patients with obstructive sleep apnea: Effects of REM suppressing medication (2001) (0)
- S34.04 Imaging noradrenergic and non-adrenergic binding of [3H]clonidine in brains from psychiatrically characterized humans (2000) (0)
- S-27-5 Distribution and regulation of imidazoline receptors in the brain (1996) (0)
- Possible involvement of infectious agents in treatment resistant bipolar depression (2018) (0)
- S34.01 Midazoline receptors: Potential markers for depression and targets of antidepressant drug development (2000) (0)
- Selective Serotonin Reuptake Inhibitors Influence Agonist‐Induced Platelet Aggregation. Preliminary Results from Co‐morbidity of Depression and Cardiovascular Disease Study (2008) (0)
- Cardiolipin Antibody: A Potential Biomarker for Depression (2022) (0)
- Single nucleotide polymorphisms in C-reactive protein (CRP) predict response to adjunctive celecoxib treatment of resistant bipolar depression (2023) (0)
- 284. HPLC determination of agmatine in rat brain and human plasma (1996) (0)
- Imidazoline receptors: potential markers for depression and targets of antidepressant drug development (1999) (0)
- P197. Systemic Inflammation Index May Predict Treatment Responsiveness Among Patients With Treatment Resistant Bipolar Depression (2022) (0)
- Front & Back Matter (2017) (0)
- 496. Index of Peripheral Inflammation is Associated With Arterial Stiffness in Treatment-Resistant Bipolar Depression (TRBDD) (2023) (0)
- Elevated Matrix Metalloproteinase 9 in Treatment Resistant Bipolar Depression (2022) (0)
- The dexamethasone suppression and TRH stimulation tests in the initial phase of depression treatment. (1985) (0)
- Atypical [3H]Clonidine Binding Sites in Human Caudate and Platelets on Cryostat‐cut Sections (2003) (0)
- Treatment with Antipsychotic Drugs: The American Perspective (1998) (0)
- Elevated salivary cortisol predicts response to adjunctive immune modulation in treatment-resistant bipolar depression (2021) (0)
- Low parasympathetic tone by heart rate variability and higher inflammation differentiates bipolar from major depression (2018) (0)
- Somatosensory amplification, depression, anxiety and pain in statin intolerant patients (2019) (0)
- Sexual Dysfunction: A Neglected Area of Knowledge (2013) (0)
- Lithium therapy. (1983) (0)
- F175. Cyclooxygenase-2 Inhibitor Combination Treatment Reduces Plasma C-Reative Protein Levels in Bipolar Depression (2018) (0)
- S97. Celecoxib Augmentation of Escitalopram in Treatment-Resistant Bipolar Depression and the Effects on Quinolinic Acid in the Kynurenine Pathway (2019) (0)
- 507. Relationship Between Vascular Endothelial Growth Factor (VEGF) and Peripheral Inflammation Markers in Treatment-Resistant Bipolar Depression Disorder (TRBDD) (2023) (0)
- Comparison of3H-para-aminoclonidine binding to different platelet preparations (2005) (0)
- S98. TITLE: Treatment Resistant Bipolar Depression: Effects of Inflammation Modulation on Tryptophan Utilization and Kynurenine Pathway Activation (2019) (0)
- Effects of Adjunctive Celecoxib on Inflammatory Biomarker, IL-8, for Treatment-Resistant Bipolar Depression: A Randomized, Double-Blind, Placebo-Controlled Trial (2021) (0)
- P164. Systemic Inflammation Response Index (SIRI) May Predict Treatment Response in Treatment-Resistant Bipolar Depression (TRBDD) (2022) (0)
- P255. L-Methylfolate Supplementation in Patients With MTHFR Polymorphisms in Major Depressive Disorder and Treatment Resistant Depression (2022) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Angelos E. Halaris?
Angelos E. Halaris is affiliated with the following schools:
